Matthew Ringel

  • Dr. Ringel is the Ralph W. Kurtz Chair, Professor of Medicine, and Director of the Division of Endocrinology and Metabolism at The Ohio State University and Arthur G. James Comprehensive Cancer Center. He is the Co-Director of the Thyroid Cancer Unit and of the Molecular Biology and Cancer Genetics Program at Ohio State. He has an active clinical practice focused on thyroid cancer. He is a member of the thyroid cancer NCCN guidelines committee, the National Cancer Institute Head and Neck Steering Committee. Dr. Ringel’s NIH-funded laboratory is interested in defining the signaling pathways responsible for aggressive thyroid cancer behavior.


Leave a Reply

  • Upcoming Events


    World Congress on Thyroid Cancer 3.5
    June 20 – 22, 2019
    Rome, Italy

    World Congress on Thyroid Cancer 4.0
    July 29 – August 1, 2021
    Boston, Massachusetts


  • WCTC3.5 Steering Committee:


    Rocco Bellatone, Co-Chair
    Celestino Lombardi, Co-Chair
    Gregory W. Randolph, MD
    Bryan McIver, MD
    Jeremy Freeman, MD
    Ian J. Witterick, MD
    Ashok R. Shaha, MD
    Jatin P. Shah, MD